Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05428969 |
Title | A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Faron Pharmaceuticals Ltd |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | FIN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope National Medical Center | RECRUITING | Duarte | California | 91010 | United States | Details |
Yale Cancer Center | RECRUITING | New Haven | Connecticut | 06510 | United States | Details |
UNC Lineberger Comprehensive Cancer Center | RECRUITING | Chapel Hill | North Carolina | 27599 | United States | Details |
University of Texas, MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
Helsinki University Hospital | RECRUITING | Helsinki | 00029 | Finland | Details | |
Kuopio University Hospital | RECRUITING | Kuopio | 70210 | Finland | Details | |
Oulu University Hospital | RECRUITING | Oulu | 90029 | Finland | Details | |
Tampere University Hospital | RECRUITING | Tampere | 33520 | Finland | Details |